about
TLR2, TLR4 and the MYD88 signaling pathway are crucial for neutrophil migration in acute kidney injury induced by sepsisAdditive Renoprotection by Pioglitazone and Fenofibrate against Inflammatory, Oxidative and Apoptotic Manifestations of Cisplatin Nephrotoxicity: Modulation by PPARsA Role for Tubular Necroptosis in Cisplatin-Induced AKINephrotoxicity as a cause of acute kidney injury in children.Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury.Anaphylatoxin C5a contributes to the pathogenesis of cisplatin-induced nephrotoxicity.Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model.The effects of a selective inhibitor of c-Fos/activator protein-1 on endotoxin-induced acute kidney injury in mice.Epidermal growth factor receptor inhibition with erlotinib partially prevents cisplatin-induced nephrotoxicity in ratsPoly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury.Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathyIL-33 exacerbates acute kidney injuryCisplatin nephrotoxicity involves mitochondrial injury with impaired tubular mitochondrial enzyme activity.Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effectsCisplatin-induced nephrotoxicity alters blood pressure response to angiotensin II administration in rats.Combination therapy with cisplatin and anti-4-1BB: synergistic anticancer effects and amelioration of cisplatin-induced nephrotoxicityLoss of TIMP3 enhances interstitial nephritis and fibrosis.NLRP3 inflammasome knockout mice are protected against ischemic but not cisplatin-induced acute kidney injury.A review of the potential protective effects of pentoxifylline against drug-induced nephrotoxicity.Therapeutic potential of cannabinoids in counteracting chemotherapy-induced adverse effects: an exploratory review.Comparative study of the possible protective effects of cinnamic acid and cinnamaldehyde on cisplatin-induced nephrotoxicity in rats.Interaction among nitric oxide, reactive oxygen species, and antioxidants during endotoxemia-related acute renal failure.Protection against cisplatin-induced nephrotoxicity in mice by Curcuma comosa Roxb. ethanol extract.Hesperidin and rutin, antioxidant citrus flavonoids, attenuate cisplatin-induced nephrotoxicity in rats.Amelioration of cisplatin-induced nephrotoxicity in rats by triterpenoid saponin of Terminalia arjuna.Regulation of renal organic ion transporters in cisplatin-induced acute kidney injury and uremia in rats.Effect of Nigella sativa L. seed extract on cisplatin-induced delay in gastric emptying in Sprague-Dawley rats.Raloxifene Inhibits NF-kB Pathway and Potentiates Anti-Tumour Activity of Cisplatin with Simultaneous Reduction in its Nephrotoxictiy.Cisplatin-induced renal inflammation is ameliorated by cilastatin nephroprotection.Effects of genetic variants in SLC22A2 organic cation transporter 2 and SLC47A1 multidrug and toxin extrusion 1 transporter on cisplatin-induced adverse events.Sirtuin 7 Deficiency Ameliorates Cisplatin-induced Acute Kidney Injury Through Regulation of the Inflammatory Response.Visualization of oxidative injury in the mouse kidney using selective superoxide anion fluorescent probes
P2860
Q27302311-F111AFDF-7D7A-4521-8B76-1BA51DD964A3Q28550672-08F39FBB-E34E-420E-AB7D-EFDDFD51C254Q28608321-48B697FE-BBC4-4F38-97CC-494D6884CD2CQ30319678-068AF732-8199-4FC1-A802-7445E386DDE2Q33229071-CEFD1EF4-7FF2-4E13-859C-1600EEC8AAE4Q33792047-3FE7BEB4-1EA2-41A2-BE25-6B0516C103C1Q33847549-D9B7636F-571A-4625-A878-B789CFEADBA1Q34098258-362829B3-A6D1-4355-B787-C59846A8284EQ34486031-57E886D8-7902-4450-BAEE-3995856B5C9CQ35413351-D3B1167C-7714-4363-BF6F-269E114AD8AAQ35514172-8096CC0D-9019-49A6-9A45-8F3130075853Q35659099-370E1B2D-47B8-4361-BD67-464FE7E5275EQ35758456-5EDE936E-79BB-4E80-BA86-24F4D4CEA9FFQ36285862-11D172FB-B809-4307-96BC-EBF100299628Q36649479-EB024FF1-9D61-401F-9677-380637699539Q36755727-5F67F798-0458-407E-ACD6-18E313C67F96Q36906616-CD8C7514-6201-4BB5-9996-9BA9F97FBBD0Q37211116-2D3DBB3C-46EB-4042-8850-768B4ED2198BQ37422647-91A66C50-81C8-4EF6-9460-63EE94C45FE4Q38062340-381A0E45-E98E-46EC-ACEC-BE62D4B3BD77Q38287745-F5417F3B-E4BF-489B-972F-13B2220FBFF7Q42709787-667E6BEB-5050-487E-86CB-9EA77D08000AQ44295549-4F561015-9D4E-4329-BA89-9B72B6AC6674Q45964337-9EFAD448-A345-400B-896C-2418772AB562Q46157347-2B7C3729-D977-463E-9B60-DAD1A7367C3BQ46365540-3EB3DC9E-5CAE-4E32-AE0B-A2D9533E5835Q46494137-6A1A9D43-604E-4E11-BE9D-03E35FE0FDF6Q46905273-E922807E-8B16-43BB-9C3B-AE0B26824C0BQ48124030-64AD67AC-17F1-4D7A-B953-5DA466B41A52Q48807960-6C9F1A49-11D3-4512-9ED5-EB19B6DF9B25Q50511478-BCB1067D-A42D-42F1-A079-9F1526B1638FQ52590872-317F670E-8D56-44A5-81ED-4AC86B3EA5BCQ58554848-406CA5FA-8D96-46B3-829E-2F42F287A02F
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Cancer therapy and renal injury.
@en
Cancer therapy and renal injury.
@nl
type
label
Cancer therapy and renal injury.
@en
Cancer therapy and renal injury.
@nl
prefLabel
Cancer therapy and renal injury.
@en
Cancer therapy and renal injury.
@nl
P2860
P356
P1476
Cancer therapy and renal injury.
@en
P2860
P304
P356
10.1172/JCI0216568
P407
P577
2002-09-01T00:00:00Z